Blueberries Medical Corp (BBRRF)
OTHER OTC:BBRRF
BBRRF Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume2.00K
Average Volume (3M)8.85K
Market Cap
$5.38M
Enterprise Value$7.33M
Total Cash (Recent Filing)$102.83K
Total Debt (Recent Filing)$7.47K
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume7,882
30 Day Avg. Volume8,851
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue24.45
Enterprise Value/Gross Profit71.97
Enterprise Value/Ebitda-10.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low TTM debt-to-equity (~0.02) materially lowers financial risk and interest burdens, giving management flexibility to prioritize R&D or commercialization. Over a 2–6 month horizon this strengthens survivability and reduces refinancing pressure while cash burn is addressed.
Positive Gross Margin ImprovementA positive gross margin (~32%) and recovery from prior negative margins indicate underlying product economics can be profitable at the unit level. If overhead is controlled, this structural margin provides a viable path to operating leverage and sustainable profitability as revenue stabilizes.
Improving Cash Burn TrendOperating and free cash flow remain negative but have improved versus 2025, signaling operational stabilization. A declining cash burn trajectory reduces near-term financing needs and indicates management has started to restrain outflows, improving runway and optionality over the medium term.
Bears Say
Sharp Revenue DeclineA very large TTM revenue decline (~-400%) erodes scale and undermines the business model: lower volumes reduce operating leverage, jeopardize fixed-cost coverage and R&D investment capacity. Recovering demand is critical; absent it, margin gains may not translate to profitability.
Deep Losses And Negative Cash FlowPersistent operating and net losses with negative operating and free cash flow imply ongoing cash burn and a structural inability to self-fund growth. Over months this necessitates external financing or asset sales, which can dilute shareholders and constrain long-term strategic investments.
Equity Erosion And Negative ROESubstantial equity decline and persistently negative ROE signal prolonged value destruction and a depleted capital cushion. This reduces the firm's ability to absorb setbacks, limits borrowing capacity despite low leverage, and increases the probability of dilutive capital raises or restructuring.
Blueberries Medical News
BBRRF FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is $5.38M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Sep 02, 2026 which is in 93 days.
How were Blueberries Medical Corp’s earnings last quarter?
Currently, no data Available
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in BBRRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. The company is headquartered in Bogotá, Colombia.
Technical Analysis
Ownership Overview
7.19% Insiders
<0.01% Other Institutional Investors
92.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---